Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

NCT04095143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2022-11-14

No results posted yet for this study

Summary

Fluid overload is associated with adverse outcomes in patients with severe acute kidney injury. It remains unclear if fluid overload is merely a marker of disease severity or if organ congestion is a mediator of complications. Point-of-care ultrasound could be a modality used to assess organ congestion and its clinical implications. The objective of this study is to determine whether ultrasound markers of organ congestion are associated with major adverse kidney events in critically ill patients with severe acute kidney injury.

Conditions

Interventions

DIAGNOSTIC_TEST

Portal vein flow

Doppler assessment performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Intra-renal flow

Doppler assessment performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Hepatic vein flow

Doppler assessment performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Pulmonary B-lines

Ultrasound assessment of performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Dimensions of the inferior vena cava

Ultrasound assessment of performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Left ventricular function

Ultrasound assessment of performed on day 0, 3 and 7.

DIAGNOSTIC_TEST

Right ventricular function

Ultrasound assessment of performed on day 0, 3 and 7.

Sponsors & Collaborators

  • Unity Health Toronto

    collaborator OTHER
  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • University of Kentucky

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • Montreal Heart Institute

    collaborator OTHER
  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • William Beaubien-Souligny, MD · CHUM

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2022-01-01
Completion
2022-09-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04095143 on ClinicalTrials.gov